SERPIND1 and ovarian cancer: The expression of the SERPIND1 gene was inhibited in the ovarian cancer cell lines CAOV3 and OVCAR3, compared with the controls, and these cells showed a significant reduction in proliferation, migration, and invasion capacities, a reduced proportion of S-phase cells, and a significant increase in apoptotic rate.